| John Salvatore Anastasi, MD | |
|
1348 Walton Way Ste 5700, Augusta, GA 30901 | |
| (706) 722-8242 | |
| (706) 722-8351 |
| Full Name | John Salvatore Anastasi |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 44 Years |
| Location | 1348 Walton Way Ste 5700, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285691113 | NPI | - | NPPES |
| 0011750750001 | Medicaid | PA | |
| 251607393 | Other | PA | CIGNA/HEALTHSOURCE |
| 72275 | Other | PA | MED PLUS |
| 1401306 | Other | PA | UMWA |
| 060008007 | Other | PA | RR MEDICARE |
| PZ873 | Other | FL | FL HF MA |
| 03240 | Other | PA | HEALTH AMERICA/HEALTH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aultman Health Care In Your Home | Canton, OH | Home health agency |
| Aultman Hospital | Canton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aultman Deuble Heart And Vascular Hospital, Llc | 1850726126 | 87 |
News Archive
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Institute of Food Research scientists have discovered an unexpected synergy that helps break down fat. The discovery provides a focus to find ways to slow down fat digestion, and ultimately to create food structures that induce satiety.
The University of Arkansas will host the 2010 Advances in Breast Cancer Research workshop sponsored by the National Science Foundation on Oct. 26-29. The workshop will bring together researchers in nanotechnology, biomagnetics, microwave imaging, acoustics, laser and biochemistry fields with researchers from radiology, oncology and breast surgery.
The Department of Health and Human Services has selected the Hospital of the University of Pennsylvania (HUP) as one of five hospitals that will take part in a nationwide initiative designed to train more nurses at a higher level.
› Verified 4 days ago
| Entity Name | Genesis Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063663433 PECOS PAC ID: 7719040385 Enrollment ID: O20090107000547 |
News Archive
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Institute of Food Research scientists have discovered an unexpected synergy that helps break down fat. The discovery provides a focus to find ways to slow down fat digestion, and ultimately to create food structures that induce satiety.
The University of Arkansas will host the 2010 Advances in Breast Cancer Research workshop sponsored by the National Science Foundation on Oct. 26-29. The workshop will bring together researchers in nanotechnology, biomagnetics, microwave imaging, acoustics, laser and biochemistry fields with researchers from radiology, oncology and breast surgery.
The Department of Health and Human Services has selected the Hospital of the University of Pennsylvania (HUP) as one of five hospitals that will take part in a nationwide initiative designed to train more nurses at a higher level.
› Verified 4 days ago
| Entity Name | Aultman Deuble Heart & Vascular Hospital, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306495718 PECOS PAC ID: 1850726126 Enrollment ID: O20200114002347 |
News Archive
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Institute of Food Research scientists have discovered an unexpected synergy that helps break down fat. The discovery provides a focus to find ways to slow down fat digestion, and ultimately to create food structures that induce satiety.
The University of Arkansas will host the 2010 Advances in Breast Cancer Research workshop sponsored by the National Science Foundation on Oct. 26-29. The workshop will bring together researchers in nanotechnology, biomagnetics, microwave imaging, acoustics, laser and biochemistry fields with researchers from radiology, oncology and breast surgery.
The Department of Health and Human Services has selected the Hospital of the University of Pennsylvania (HUP) as one of five hospitals that will take part in a nationwide initiative designed to train more nurses at a higher level.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Salvatore Anastasi, MD Po Box 1524, Augusta, GA 30903-1524 Ph: (706) 774-7263 | John Salvatore Anastasi, MD 1348 Walton Way Ste 5700, Augusta, GA 30901 Ph: (706) 722-8242 |
News Archive
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Institute of Food Research scientists have discovered an unexpected synergy that helps break down fat. The discovery provides a focus to find ways to slow down fat digestion, and ultimately to create food structures that induce satiety.
The University of Arkansas will host the 2010 Advances in Breast Cancer Research workshop sponsored by the National Science Foundation on Oct. 26-29. The workshop will bring together researchers in nanotechnology, biomagnetics, microwave imaging, acoustics, laser and biochemistry fields with researchers from radiology, oncology and breast surgery.
The Department of Health and Human Services has selected the Hospital of the University of Pennsylvania (HUP) as one of five hospitals that will take part in a nationwide initiative designed to train more nurses at a higher level.
› Verified 4 days ago
Richard Lee, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 | |
Christopher Ellington, BMBS Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1348 Walton Way Ste 5700, Augusta, GA 30901 Phone: 706-722-8242 Fax: 706-722-8351 | |
Dr. Holland Victor Moore, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 747 Aumond Rd, Augusta, GA 30909 Phone: 706-738-4222 | |
Michael A Watts, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1348 Walton Way, Suite 5700, Augusta, GA 30901 Phone: 706-722-8242 Fax: 706-722-8351 | |
Timothy J Hunter, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 820 Saint Sebastian Way, Suite 6 - B, Augusta, GA 30901 Phone: 706-722-8242 Fax: 706-722-8351 | |
Dr. William Clifford Kitchens, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1348 Walton Way Ste 5700, Augusta, GA 30901 Phone: 706-722-8242 Fax: 706-722-8351 |